AIT Bioscience Announces Emilio Córdova as Senior Vice President of Business Development -AIT Bioscience

AIT Bioscience Announces Emilio Córdova as Senior Vice President of Business Development

 

Friday, March 23, 2012

  

AIT Bioscience is expanding its executive leadership team as it names

Emilio Córdova, Ph.D., MBA as its senior vice president of business development.

Córdova spent the past three years as vice president of business development at

Worldwide Clinical Trials Drug Development Solutions (formerly Cedra Corporation) in Austin,

Texas. The AIT Bioscience position brings Córdova back to Indiana where he spent much of his

career at West Lafayette-based Bioanalytical Systems, Inc. serving in a number of roles,

including vice president of business development.

 

“I am excited about teaming up with AIT Bioscience President Ron Shoup again. He and his

team have developed a contract research organization that is proving to be a game changer in our

industry as they have created the first paperless bioanalytical laboratory in the world, providing

the tools and quality processes to deliver faster results to clients,” said Córdova.

 

AIT Bioscience’s paperless system enables QA’d data delivery in 10 business days or less, a

much shorter timeframe than the typical data delivery of three to four weeks.

 

“Being involved in a company setting new standards in the field of bioanalytical testing is

something that I couldn’t pass up,” added Córdova. “Returning to Indiana, which is a major

player in the life sciences nationally, was very attractive to me.”

 

In September 2011, AIT Bioscience opened a new 18,000 square foot state-of-the-art laboratory

in Indianapolis, Ind. that was built for both small molecule and protein bioanalysis.

 

“Emilio Córdova brings to AIT Bioscience not only a strong awareness of the drug development

landscape but also the scientific and regulatory knowledge that innovative biotechs and pharmas

need to make credible submissions to the FDA,” said Shoup. “Emilio is already at work building

strategic partnerships with preclinical and clinical CROs that complement our analytical

chemistry skills in mass spectrometry and immunoassay.”

 

Córdova holds a Bachelor of Arts from Drew University; a Master of Science and Doctor of

Philosophy from the University of Miami (Fla.); and did post-doctoral research with Professor

George Whitesides at Harvard. He also earned a Master of Business Administration from Purdue

University.

 

 

About AIT Bioscience:

 

AIT Bioscience, LLC, headquartered in Indianapolis, Ind., is a bioanalytical contract research

organization supporting pre-clinical and phase I-III clinical trials. AIT Bioscience provides

robust analytical methods, painless sample logistics, and rapid sample analyses that support

programs through to the investigational new drug and new drug applications. AIT Bioscience has

created a new standard for quantitative bioanalytical analysis and drug development in support of

small biotech and large pharmaceutical companies. Learn more about AIT Bioscience at

www.AITBioscience.com

 

 

.